Microphysiological Drug-Testing Platform for Identifying Responses to Prodrug Treatment in Primary Leukemia.

Saved in:
Bibliographic Details
Title: Microphysiological Drug-Testing Platform for Identifying Responses to Prodrug Treatment in Primary Leukemia.
Authors: Gökçe F; Department of Biosystems Science and Engineering, ETH Zurich, Basel, BS, 4058, Switzerland., Kaestli A; Department of Biosystems Science and Engineering, ETH Zurich, Basel, BS, 4058, Switzerland., Lohasz C; Department of Biosystems Science and Engineering, ETH Zurich, Basel, BS, 4058, Switzerland., de Geus M; Department of Biosystems Science and Engineering, ETH Zurich, Basel, BS, 4058, Switzerland., Kaltenbach HM; Department of Biosystems Science and Engineering, ETH Zurich, Basel, BS, 4058, Switzerland., Renggli K; Department of Biosystems Science and Engineering, ETH Zurich, Basel, BS, 4058, Switzerland., Bornhauser B; Children's Research Center, University Children's Hospital Zurich, Zurich, ZH, 8008, Switzerland., Hierlemann A; Department of Biosystems Science and Engineering, ETH Zurich, Basel, BS, 4058, Switzerland., Modena M; Department of Biosystems Science and Engineering, ETH Zurich, Basel, BS, 4058, Switzerland.
Source: Advanced healthcare materials [Adv Healthc Mater] 2023 Jan; Vol. 12 (6), pp. e2202506. Date of Electronic Publication: 2023 Jan 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101581613 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-2659 (Electronic) Linking ISSN: 21922640 NLM ISO Abbreviation: Adv Healthc Mater Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2192-2659
DOI:10.1002/adhm.202202506